We Improve the Discoverability of Press Releases
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
Latest News
Aster App Tackles Women's Nighttime Safety Fears with Emergency Tech
about 3 hours ago
PickleJar Seizes Opportunity After Ticketmaster Antitrust Verdict
about 3 hours ago
Soligenix Reports Positive CTCL Therapy Data in Phase 3 Trial
about 4 hours ago
Major Cryptos Show Resilience as Geopolitical Tensions Rise
about 4 hours ago
HR News
HR.com Honors 2026 Hospitality Innovators in Workforce Management
1 day ago
Peapack Capital Promotes Roz Ostler to Lead $1B Asset Management
3 days ago
AI Transforms Entry-Level Jobs, Creating New Career Pathways
3 days ago
Metavesco Launches Epic Labor AI to Tackle Data Center Workforce Crisis
3 days ago
One Dynamics: Singapore's Trusted Team Building Partner Delivers Customized Results
7 days ago
Business News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 6 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 6 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in about 1 month
UGI Utilities Launches Hazleton System Upgrades, Offers Gas Conversion
about 2 hours ago
Roth Capital Taps Veteran Seth Appel to Lead ATM Banking, Co-Manage Fund
about 2 hours ago
Crypto News
Major Cryptos Show Resilience as Geopolitical Tensions Rise
about 4 hours ago
Iran Eyes Bitcoin for Oil Transit, Igniting Crypto Debate
2 days ago
Forward Industries Appoints Mark Brazier as CFO to Boost Solana Treasury Strategy
2 days ago
Datavault AI Lists Meme Coins & RWA Tokens on Biconomy for Global Reach
3 days ago
Datavault AI Lists Meme Coins & RWA Tokens on Biconomy Exchange
3 days ago
Health News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 6 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 6 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in about 1 month
Soligenix Reports Positive CTCL Therapy Data in Phase 3 Trial
about 4 hours ago
New AI Tool Aims to Revolutionize Early Lung Cancer Detection
about 4 hours ago
Technology News
Aster App Tackles Women's Nighttime Safety Fears with Emergency Tech
about 3 hours ago
PickleJar Seizes Opportunity After Ticketmaster Antitrust Verdict
about 3 hours ago
Datavault AI Launches Quantum-Ready GPU Network to Challenge Hyperscaler Dominance
about 4 hours ago
Sodium-Ion Batteries Emerge as Potential Solution to EV Supply Chain Crisis
about 4 hours ago
MIT Report: AI Success Demands Ongoing Data Consent, Not One-Time Approval
about 4 hours ago
Events & Conferences
PickleJar Seizes Opportunity After Ticketmaster Antitrust Verdict
about 3 hours ago
American Fusion Advances Commercial Strategy at ARPA-E Summit, Targets Data Centers
about 5 hours ago
Bowler Pons Expands from Defense to Commercial Tech at eMerge Americas 2026
about 6 hours ago
PFISTERER Reports Record 2025 Growth, Targets EUR 800M+ Revenue by 2030
about 20 hours ago
INFICON Announces Q1 2026 Results Schedule with Live Web Conference
about 20 hours ago